Thirona spins out retina business
Click Here to Manage Email Alerts
Thirona, which specializes in artificial intelligence-assisted medical imaging, is spinning out its retina division, according to a press release.
The decision comes on the heels of the recent expansion of the company’s flagship software, RetCAD, which analyzes color fundus imaging for the presence of age-related macular degeneration, diabetic retinopathy and glaucoma.
Thirona Retina BV will focus on the eye diseases market and act as a stand-alone entity, the release said.
Mark van Grinsven, managing director of Thirona Retina BV, said the move will allow the retina team to concentrate on AI solutions for eye diseases.
“The Class IIa European Medical Device Regulation CE-certified RetCAD is already being integrated by all major fundus camera providers such as iCare, Topcon, Canon, Tomey and Nidek,” van Grinsven said in the release. “More dedication will allow us to speed up the expansion to other channels and to grow our leadership position globally.”